These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 9112462

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study.
    Chan AK, Wong AO, Langevin J, Jenken D, Heine J, Buie D, Johnson DR.
    Int J Radiat Oncol Biol Phys; 2000 Oct 01; 48(3):843-56. PubMed ID: 11020583
    [Abstract] [Full Text] [Related]

  • 3. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
    Movsas B, Hanlon AL, Lanciano R, Scher RM, Weiner LM, Sigurdson ER, Hoffman JP, Eisenberg BL, Cooper HS, Provins S, Coia LR.
    Int J Radiat Oncol Biol Phys; 1998 Aug 01; 42(1):43-50. PubMed ID: 9747818
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.
    Uzcudun AE, Batlle JF, Velasco JC, Sánchez Santos ME, Carpeño Jde C, Grande AG, Juberías AM, Piñeiro EH, Olivar LM, García AG.
    Dis Colon Rectum; 2002 Oct 01; 45(10):1349-58. PubMed ID: 12394434
    [Abstract] [Full Text] [Related]

  • 5. Preoperative concurrent 5-fluorouracil infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma.
    Chan A, Wong A, Langevin J, Khoo R.
    Int J Radiat Oncol Biol Phys; 1993 Apr 02; 25(5):791-9. PubMed ID: 8478229
    [Abstract] [Full Text] [Related]

  • 6. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.
    Pucciarelli S, Toppan P, Friso ML, Russo V, Pasetto L, Urso E, Marino F, Ambrosi A, Lise M.
    Dis Colon Rectum; 2004 Nov 02; 47(11):1798-807. PubMed ID: 15622571
    [Abstract] [Full Text] [Related]

  • 7. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation.
    Valentini V, Coco C, Cellini N, Picciocchi A, Genovesi D, Mantini G, Barbaro B, Cogliandolo S, Mattana C, Ambesi-Impiombato F, Tedesco M, Cosimelli M.
    Int J Radiat Oncol Biol Phys; 1998 Mar 15; 40(5):1067-75. PubMed ID: 9539561
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mitomycin-C/5-fluorouracil/leucovorin and hyperfractionated radiation therapy for rectal carcinoma: a phase II study with long-term follow-up.
    Nabhan C, Ragam A, Samuels B, Milton DT, Prasad L, Hooberman A, Hartsell W, Anthony A, Weisman R, Bitran JD.
    Clin Colorectal Cancer; 2007 Mar 15; 6(6):436-41. PubMed ID: 17531107
    [Abstract] [Full Text] [Related]

  • 10. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
    Myerson RJ, Valentini V, Birnbaum EH, Cellini N, Coco C, Fleshman JW, Gambacorta MA, Genovesi D, Kodner IJ, Picus J, Ratkin GA, Read TE.
    Int J Radiat Oncol Biol Phys; 2001 Aug 01; 50(5):1299-308. PubMed ID: 11483342
    [Abstract] [Full Text] [Related]

  • 11. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
    Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):665-77. PubMed ID: 15708244
    [Abstract] [Full Text] [Related]

  • 12. Preoperative radiotherapy and concurrent chemotherapy with bolus 5-fluorouracil for rectal cancer: a prospective analysis of 98 patients.
    Wygoda M, Rottenberg Y, Kadouri L, Pikarsky A, Hubert A.
    Tumori; 2010 Mar 01; 96(5):709-12. PubMed ID: 21302617
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
    Tepper JE, O'Connell M, Niedzwiecki D, Hollis DR, Benson AB, Cummings B, Gunderson LL, Macdonald JS, Martenson JA, Mayer RJ.
    J Clin Oncol; 2002 Apr 01; 20(7):1744-50. PubMed ID: 11919230
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.
    Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, Saltz L, Sigurdson ER, Frankel J.
    J Clin Oncol; 1992 Jan 01; 10(1):79-84. PubMed ID: 1727928
    [Abstract] [Full Text] [Related]

  • 18. Five fractions of preoperative radiotherapy for selected cases of rectal carcinoma: long-term tumor control and tolerance to treatment.
    Myerson RJ, Genovesi D, Lockett MA, Birnbaum E, Fleshman J, Fry R, Kodner I, Menteer J, Picus J, Read T, Walz B.
    Int J Radiat Oncol Biol Phys; 1999 Feb 01; 43(3):537-43. PubMed ID: 10078634
    [Abstract] [Full Text] [Related]

  • 19. Chemotherapy with preoperative radiotherapy in rectal cancer.
    Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC, EORTC Radiotherapy Group Trial 22921.
    N Engl J Med; 2006 Sep 14; 355(11):1114-23. PubMed ID: 16971718
    [Abstract] [Full Text] [Related]

  • 20. Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer: preliminary results.
    Tjandra JJ, Reading DM, McLachlan SA, Gunn IF, Green MD, McLaughlin SJ, Millar JL, Pedersen JS.
    Dis Colon Rectum; 2001 Aug 14; 44(8):1113-22. PubMed ID: 11535850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.